Don’t delay: Cancer patients need both doses of COVID vaccineMarch 15, 2021Patient & Survivor CareAggressive LymphomasB Cell LymphomaT Cell LymphomasMultiple MyelomaMantle Cell LymphomaIndolent Lymphoma
Survey quantifies COVID-19’s impact on oncologySeptember 20, 2020COVID-19 UpdatesDLBCLAggressive LymphomasALLAMLAnemiaCLL
Hepatitis screening now for all patients with cancer on therapyAugust 6, 2020Patient & Survivor CareHodgkin LymphomaIndolent LymphomaMantle Cell LymphomaB Cell LymphomaAggressive Lymphomas
Survival data reported from largest CAR T trial in B-cell lymphomaDecember 20, 2019B Cell LymphomaDLBCLIndolent Lymphoma
5F9 plus rituximab take a bite out of drug-resistant NHLJune 18, 2019Aggressive LymphomasIndolent LymphomaB Cell Lymphoma
FDA approves lenalidomide/rituximab for previously treated FL, MZLMay 29, 2019B Cell LymphomaIndolent Lymphoma
High survival in relapsed FL after primary radiotherapyMarch 21, 2019Indolent LymphomaB Cell Lymphoma
BCL expression intensity key in distinguishing FL lesionsFebruary 10, 2019Indolent LymphomaB Cell Lymphoma
GALLIUM: MRD response correlates with outcomes in follicular lymphomaJanuary 31, 2019Indolent Lymphoma
